2016
$97M
from 12 investors over 12 rounds
Neurophth Therapeutics / 纽福斯生物科技有限公司 raised $97M on August 9, 2023
Investors: CMB International, Sequoia Capital China, 武汉光谷金融控股集团有限公司 and 广州金融控股集团
Neurophth Therapeutics / 纽福斯生物科技有限公司 raised $60M on November 23, 2021
Investors: Sequoia Capital China, Sunshine Insurance Group and CMB International
Neurophth Therapeutics / 纽福斯生物科技有限公司 raised $62M on February 9, 2021
Investors: Sequoia Capital China, Northern Light Venture Capital and Harvest Capital Management, Inc
Neurophth Therapeutics / 纽福斯生物科技有限公司 raised $18M on April 8, 2020
Investors: Sequoia Capital China
Neurophth Therapeutics / 纽福斯生物科技有限公司 raised undisclosed on January 1, 2018
Investors: Northern Light Venture Capital